Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9273 | 1171 | 25.9 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
1561 | 2 | MANNHEIMIA HAEMOLYTICA//AZITHROMYCIN//BOVINE RESPIRATORY DISEASE | 7369 |
9273 | 1 | AZITHROMYCIN//CLARITHROMYCIN//DIRITHROMYCIN | 1171 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AZITHROMYCIN | authKW | 363543 | 11% | 11% | 125 |
2 | CLARITHROMYCIN | authKW | 175728 | 8% | 8% | 88 |
3 | DIRITHROMYCIN | authKW | 124155 | 1% | 48% | 10 |
4 | CAS 96128 89 1 | authKW | 78224 | 0% | 100% | 3 |
5 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | journal | 73195 | 16% | 2% | 187 |
6 | MACROLIDES | authKW | 58649 | 5% | 4% | 61 |
7 | AZALIDE | authKW | 55462 | 1% | 21% | 10 |
8 | AZITHROMYCIN EXTENDED RELEASE | authKW | 52149 | 0% | 100% | 2 |
9 | AZITHROMYCIN INVITRO STUDIES | authKW | 52149 | 0% | 100% | 2 |
10 | CLARITHROMYCIN BIOEQUIVALENCE CLINICAL PHARMACOKINETICS | authKW | 52149 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 15788 | 35% | 0% | 406 |
2 | Pharmacology & Pharmacy | 13022 | 61% | 0% | 712 |
3 | Microbiology | 8109 | 35% | 0% | 411 |
4 | Medicine, General & Internal | 278 | 9% | 0% | 102 |
5 | Medicine, Research & Experimental | 137 | 5% | 0% | 61 |
6 | Respiratory System | 60 | 2% | 0% | 29 |
7 | Immunology | 54 | 5% | 0% | 61 |
8 | Pathology | 50 | 3% | 0% | 30 |
9 | Primary Health Care | 40 | 1% | 0% | 8 |
10 | Veterinary Sciences | 39 | 3% | 0% | 37 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | YEDITEPE HLTH SERV | 34765 | 0% | 67% | 2 |
2 | ABBOTT INT | 26075 | 0% | 100% | 1 |
3 | BIOEQUIVALENCE PHARMACEUT SCI | 26075 | 0% | 100% | 1 |
4 | BIOQUIVALENCE TEST | 26075 | 0% | 100% | 1 |
5 | CLIN OTORINOLARINGIATRIA | 26075 | 0% | 100% | 1 |
6 | CNRSURA 362 | 26075 | 0% | 100% | 1 |
7 | DRUG SURVEILLANC PROGRAM | 26075 | 0% | 100% | 1 |
8 | EXPTL THER EUT PHARMACOL | 26075 | 0% | 100% | 1 |
9 | FARMACOL CHEMOTER IA | 26075 | 0% | 100% | 1 |
10 | FDN POLICLIN MANGIAGALLI REGINA | 26075 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 73195 | 16% | 2% | 187 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 14772 | 10% | 0% | 116 |
3 | DRUG INVESTIGATION | 10821 | 1% | 4% | 11 |
4 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 6815 | 2% | 1% | 22 |
5 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 6264 | 3% | 1% | 39 |
6 | PATHOLOGIE BIOLOGIE | 4670 | 2% | 1% | 28 |
7 | JOURNAL OF CHEMOTHERAPY | 4614 | 2% | 1% | 21 |
8 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 3930 | 2% | 1% | 27 |
9 | CHEMOTHERAPY | 3304 | 2% | 1% | 18 |
10 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 3266 | 2% | 1% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AZITHROMYCIN | 363543 | 11% | 11% | 125 | Search AZITHROMYCIN | Search AZITHROMYCIN |
2 | CLARITHROMYCIN | 175728 | 8% | 8% | 88 | Search CLARITHROMYCIN | Search CLARITHROMYCIN |
3 | DIRITHROMYCIN | 124155 | 1% | 48% | 10 | Search DIRITHROMYCIN | Search DIRITHROMYCIN |
4 | CAS 96128 89 1 | 78224 | 0% | 100% | 3 | Search CAS+96128+89+1 | Search CAS+96128+89+1 |
5 | MACROLIDES | 58649 | 5% | 4% | 61 | Search MACROLIDES | Search MACROLIDES |
6 | AZALIDE | 55462 | 1% | 21% | 10 | Search AZALIDE | Search AZALIDE |
7 | AZITHROMYCIN EXTENDED RELEASE | 52149 | 0% | 100% | 2 | Search AZITHROMYCIN+EXTENDED+RELEASE | Search AZITHROMYCIN+EXTENDED+RELEASE |
8 | AZITHROMYCIN INVITRO STUDIES | 52149 | 0% | 100% | 2 | Search AZITHROMYCIN+INVITRO+STUDIES | Search AZITHROMYCIN+INVITRO+STUDIES |
9 | CLARITHROMYCIN BIOEQUIVALENCE CLINICAL PHARMACOKINETICS | 52149 | 0% | 100% | 2 | Search CLARITHROMYCIN+BIOEQUIVALENCE+CLINICAL+PHARMACOKINETICS | Search CLARITHROMYCIN+BIOEQUIVALENCE+CLINICAL+PHARMACOKINETICS |
10 | CLARITHROMYCIN SUSPENSION | 52149 | 0% | 100% | 2 | Search CLARITHROMYCIN+SUSPENSION | Search CLARITHROMYCIN+SUSPENSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOEPELMAN, IM , SCHNEIDER, MME , (1995) AZITHROMYCIN - THE FIRST OF THE TISSUE-SELECTIVE AZALIDES.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 5. ISSUE 3. P. 145-167 | 74 | 62% | 49 |
2 | LANGTRY, HD , BROGDEN, RN , (1997) CLARITHROMYCIN - A REVIEW OF ITS EFFICACY IN THE TREATMENT OF RESPIRATORY TRACT INFECTIONS IN IMMUNOCOMPETENT PATIENTS.DRUGS. VOL. 53. ISSUE 6. P. 973-1004 | 66 | 53% | 54 |
3 | ZHANEL, GG , DUECK, M , HOBAN, DJ , VERCAIGNE, LM , EMBIL, JM , GIN, AS , KARLOWSKY, JA , (2001) REVIEW OF MACROLIDES AND KETOLIDES - FOCUS ON RESPIRATORY TRACT INFECTIONS.DRUGS. VOL. 61. ISSUE 4. P. 443 -498 | 71 | 36% | 175 |
4 | MILNE, RJ , OLNEY, RW , GAMBLE, GD , TURNIDGE, J , (1997) TOLERABILITY OF ROXITHROMYCIN VS ERYTHROMYCIN IN COMPARATIVE CLINICAL TRIALS IN PATIENTS WITH LOWER RESPIRATORY TRACT INFECTIONS.CLINICAL DRUG INVESTIGATION. VOL. 14. ISSUE 5. P. 405-417 | 40 | 85% | 1 |
5 | PETERS, DH , CLISSOLD, SP , (1992) CLARITHROMYCIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL.DRUGS. VOL. 44. ISSUE 1. P. 117-164 | 51 | 63% | 145 |
6 | PERRY, E , LAVY, E , BRITZI, M , ZUR, G , SOBACK, S , WEISS, Y , (2014) AZITHROMYCIN PHARMACOKINETICS IN THE SERUM AND ITS DISTRIBUTION TO THE SKIN IN HEALTHY DOGS AND DOGS WITH PYODERMA.VETERINARY JOURNAL. VOL. 200. ISSUE 1. P. 122 -126 | 27 | 73% | 1 |
7 | PETERS, DH , FRIEDEL, HA , MCTAVISH, D , (1992) AZITHROMYCIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY.DRUGS. VOL. 44. ISSUE 5. P. 750-799 | 58 | 52% | 172 |
8 | GANZINGER, Y , MELBER, U , (1994) ZITHROMAX (CAPSULES, POWDER).WIENER KLINISCHE WOCHENSCHRIFT. VOL. 106. ISSUE 17. P. 563-571 | 38 | 90% | 0 |
9 | ALVAREZ-ELCORO, S , ENZLER, MJ , (1999) THE MACROLIDES: ERYTHROMYCIN, CLARITHROMYCIN, AND AZITHROMYCIN.MAYO CLINIC PROCEEDINGS. VOL. 74. ISSUE 6. P. 613 -634 | 81 | 30% | 107 |
10 | MCCONNELL, SA , AMSDEN, GW , (1999) REVIEW AND COMPARISON OF ADVANCED-GENERATION MACROLIDES CLARITHROMYCIN AND DIRITHROMYCIN.PHARMACOTHERAPY. VOL. 19. ISSUE 4. P. 404 -415 | 56 | 46% | 10 |
Classes with closest relation at Level 1 |